ANALYSIS OF EFFECTOR MECHANISMS AGAINST HTLV-I-LAV-INFECTED AND HTLV-III/LAV-INFECTED LYMPHOID-CELLS

被引：0
|
作者：
RUSCETTI, FW
MIKOVITS, JA
KALYANARAMAN, VS
OVERTON, R
STEVENSON, H
STROMBERG, K
HERBERMAN, RB
FARRAR, WL
ORTALDO, JR
机构：
[1] NCI,FREDERICK CANC RES FACIL,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21701
[2] CTR DIS CONTROL,CTR INFECT DIS,ATLANTA,GA 30333
[3] PROGRAM RESOURCES INC,FREDERICK,MD
[4] NCI,FREDERICK CANC RES FACIL,BIOL RESPONSE MODIFIERS PROGRAM,BIOL THERAPEUT BRANCH,FREDERICK,MD 21701
来源：
JOURNAL OF IMMUNOLOGY | 1986年 / 136卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3619 / 3624
页数：6
相关论文
共 50 条
  • [41] INCREASED PREVALENCE OF ANTIBODIES AGAINST LAV/HTLV-III VIRUS IN DRUG-ADDICTS IN THE FEDERAL-REPUBLIC-OF-GERMANY
    ZOULEK, G
    GURTLER, L
    EBERLE, J
    LORBEER, B
    DEINHARDT, F
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (15) : 567 - 570
  • [42] CHARACTERIZATION OF A NEW HTLV-I INFECTED CELL-LINE WHICH IS SUSCEPTIBLE TO HTLV-III AND ITS APPLICATION
    HATTORI, T
    KOITO, A
    SHIRONO, K
    MATSUSHITA, S
    MATSUOKA, M
    ASOU, N
    TAKATSUKI, K
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 66 - 66
  • [43] CROSS REACTIVE RECOGNITION OF DIFFERENT HUMAN T-LYMPHOTROPIC RETROVIRUSES BY HTLV-I AND HTLV-III/LAV SPECIFIC CYTOTOXIC LYMPHOCYTES-T (CTL)
    ROOK, A
    KOENIG, S
    MITSUYA, H
    LANE, H
    FAUCI, AS
    CLINICAL RESEARCH, 1987, 35 (03): : A463 - A463
  • [44] VIRUS ISOLATION FROM AND IDENTIFICATION OF HTLV-III/LAV-PRODUCING CELLS IN BRAIN-TISSUE FROM A PATIENT WITH AIDS
    GARTNER, S
    MARKOVITS, P
    MARKOVITZ, DM
    BETTS, RF
    POPOVIC, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (17): : 2365 - 2371
  • [45] QUANTITATIVE-DETERMINATION OF LAV HTLV-III VIRUS PRODUCTION IN CULTURED T-CELLS FROM ANTIBODY-POSITIVE HEMOPHILIC PATIENTS BY GP24 AND GP41 SPECIFIC MONOCLONAL LAV HTLV-III ANTIBODIES EMPLOYING FLOW-CYTOMETRY
    SCHNEIDER, EM
    WERNET, P
    BUEHRING, HJ
    SARIN, P
    BRACKMANN, HH
    KESSLER, M
    EGLI, H
    RICERCA IN CLINICA E IN LABORATORIO, 1986, 16 (01): : 92 - 92
  • [46] PREVALENCE OF ANTIBODIES AGAINST LAV/HTLV-III IN PATIENTS WITH TERMINAL RENAL-FAILURE DURING HEMODIALYSIS AND AFTER RENAL-TRANSPLANTATION
    FASSBINDER, W
    KUHNL, P
    NEUMAYER, HH
    OFFERMANN, G
    SEIDL, S
    SCHOEPPE, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (28-29) : 1087 - 1090
  • [47] ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME IN CHILDHOOD - IMPAIRED PRODUCTION OF INTERLEUKIN-2 BY HIV (LAV/HTLV III) INFECTED PATIENTS
    MACCARIO, R
    ARICO, M
    UGAZIO, A
    PLEBANI, A
    MONTAGNA, D
    AVANZINI, A
    MARSEGLIA, G
    CASELLI, D
    BURGIO, G
    INFECTION, 1987, 15 (02) : 99 - 104
  • [48] AMPLIFICATION OF HTLV-III/LAV INFECTION BY ANTIGEN-INDUCED ACTIVATION OF T-CELLS AND DIRECT SUPPRESSION BY VIRUS OF LYMPHOCYTE BLASTOGENIC RESPONSES
    MARGOLICK, JB
    VOLKMAN, DJ
    FOLKS, TM
    FAUCI, AS
    JOURNAL OF IMMUNOLOGY, 1987, 138 (06): : 1719 - 1723
  • [49] EVALUATION OF A NEW CONFIRMATORY ASSAY FOR ANTIBODIES AGAINST LYMPHADENOPATHY-ASSOCIATED VIRUS (LAV) HUMAN T-LYMPHOTROPIC VIRUS TYPE-III (HTLV-III)
    ABB, J
    VOX SANGUINIS, 1986, 51 (03) : 233 - 235
  • [50] EVIDENCE AGAINST TRANSMISSION OF HUMAN T-LYMPHOTROPIC VIRUS LYMPHADENOPATHY-ASSOCIATED VIRUS (HTLV-III/LAV) IN FAMILIES OF CHILDREN WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME
    KAPLAN, JE
    OLESKE, JM
    GETCHELL, JP
    KALYANARAMAN, VS
    MINNEFOR, AB
    ZABALAABLAN, M
    JOSHI, V
    DENNY, T
    CABRADILLA, CD
    ROGERS, MF
    SARNGADHARAN, MG
    SLISKI, A
    GALLO, RC
    FRANCIS, DP
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1985, 4 (05) : 468 - 471
12345